Cargando…

External validation of urinary C–C motif chemokine ligand 14 (CCL14) for prediction of persistent acute kidney injury

BACKGROUND: Persistent acute kidney injury (AKI) portends worse clinical outcomes and remains a therapeutic challenge for clinicians. A recent study found that urinary C–C motif chemokine ligand 14 (CCL14) can predict the development of persistent AKI. We aimed to externally validate urinary CCL14 f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bagshaw, Sean M., Al-Khafaji, Ali, Artigas, Antonio, Davison, Danielle, Haase, Michael, Lissauer, Matthew, Zacharowski, Kai, Chawla, Lakhmir S., Kwan, Thomas, Kampf, J. Patrick, McPherson, Paul, Kellum, John A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166095/ https://www.ncbi.nlm.nih.gov/pubmed/34059102 http://dx.doi.org/10.1186/s13054-021-03618-1

Ejemplares similares

Serial Urinary C-C Motif Chemokine Ligand 14 and Risk of Persistent Severe Acute Kidney Injury
por: Prowle, John R., et al.
Publicado: (2023)

Predicting the Development of Renal Replacement Therapy Indications by Combining the Furosemide Stress Test and Chemokine (C-C Motif) Ligand 14 in a Cohort of Postsurgical Patients
por: Meersch, Melanie, et al.
Publicado: (2023)

Analysis of urinary C–C motif chemokine ligand 14 (CCL14) and first-generation urinary biomarkers for predicting renal recovery from acute kidney injury: a prospective exploratory study
por: Qian, Ben-Shu, et al.
Publicado: (2023)

C-X-C Motif Chemokine Ligand 14 is a Unique Multifunctional Regulator of Tumor Progression
por: Yang, Xiao-Yan, et al.
Publicado: (2019)

Reduced expression of chemokine (C-C motif) ligand-2 (CCL2) in ovarian adenocarcinoma
por: Arnold, J M, et al.
Publicado: (2005)

C-C Motif Chemokine Ligand 5 (CCL5) Promotes Irradiation-Evoked Osteoclastogenesis
por: Wang, Jing, et al.
Publicado: (2023)

C-C motif chemokine 14 as a novel potential biomarker for predicting the prognosis of epithelial ovarian cancer
por: Cai, Yubo, et al.
Publicado: (2020)

Bovine C-X-C Motif Chemokine Ligand 14 Expression Is Regulated by Alternative Polyadenylation and MicroRNAs
por: Zhao, Wei, et al.
Publicado: (2023)

Serial Urinary C-C Motif Chemokine Ligand 14 and Risk of Persistent Severe Acute Kidney Injury: Erratum
Publicado: (2023)

Identification and validation of biomarkers of persistent acute kidney injury: the RUBY study
por: Hoste, Eric, et al.
Publicado: (2020)

Genetic Association of the C-C Motif Chemokine Ligand 2 (CCL2) rs1024611 Polymorphism With Periodontitis
por: Ahmed Khan, Hooriyah Laiq, et al.
Publicado: (2023)

Variants of C-C Motif Chemokine 22 (CCL22) Are Associated with Susceptibility to Atopic Dermatitis: Case-Control Studies
por: Hirota, Tomomitsu, et al.
Publicado: (2011)

Chemokine (C-C Motif) Ligand 2 (CCL2) in Sera of Patients with Type 1 Diabetes and Diabetic Complications
por: Guan, Ruili, et al.
Publicado: (2011)

Reduction in Urinary Chemokine (C-C Motif) Ligand 2 (CCL2) After Surgery-Induced Weight Loss
por: Said, Surita Binti, et al.
Publicado: (2020)

Common transcriptional programs and the role of chemokine (C-C motif) ligand 20 (CCL20) in cell migration of cholangiocarcinoma
por: Win Maung, Hay Mar, et al.
Publicado: (2020)

Does C-C Motif Chemokine Ligand 2 (CCL2) Link Obesity to a Pro-Inflammatory State?
por: Dommel, Sebastian, et al.
Publicado: (2021)

Role Of The C-C Motif Chemokine Ligand 5 (CCL5) And Its Receptor, C-C Motif Chemokine Receptor 5 (CCR5) In The Genesis Of Aldosterone-induced Hypertension, Vascular Dysfunction, And End-organ Damage
por: Costa, Rafael M., et al.
Publicado: (2023)

Inhibition of Chemokine (C-C Motif) Receptor 7 Sialylation Suppresses CCL19-Stimulated Proliferation, Invasion and Anti-Anoikis
por: Su, Mei-Lin, et al.
Publicado: (2014)

Multifaceted roles of CCL20 (C-C motif chemokine ligand 20): mechanisms and communication networks in breast cancer progression
por: Kwantwi, Louis Boafo, et al.
Publicado: (2021)

Renin angiotensin system molecules and chemokine (C-C motif) ligand 2 (CCL2) in chronic kidney disease patients
por: Schettini, Isabella Viana Gomes, et al.
Publicado: (2021)

The C-C Chemokines CCL17 and CCL22 and Their Receptor CCR4 in CNS Autoimmunity
por: Scheu, Stefanie, et al.
Publicado: (2017)

Performance of urinary C–C motif chemokine ligand 14 for the prediction of persistent acute kidney injury: a systematic review and meta-analysis
por: Chen, Yih‑Ting, et al.
Publicado: (2023)

Effect of Chemokine (C-C Motif) Ligand 7 (CCL7) and Its Receptor (CCR2) Expression on Colorectal Cancer Behaviors
por: Kurzejamska, Ewa, et al.
Publicado: (2019)

Adipose-specific C-C motif chemokine ligand (CCL) 19 overexpression drives the mice to both insulin resistance and weight gain
por: Hayashi, Masato, et al.
Publicado: (2021)

Associations of C-X-C motif chemokine ligands 1/2/8/13/14 with clinicopathological features and survival profile in patients with colorectal cancer
por: Luo, Xiaofan, et al.
Publicado: (2022)

Serum C‐X‐C motif chemokine ligand 14 levels are associated with serum C‐peptide and fatty liver index in type 2 diabetes mellitus patients
por: Matsushita, Yuriko, et al.
Publicado: (2020)

C-C Motif Ligand 20 (CCL20) and C-C Motif Chemokine Receptor 6 (CCR6) in Human Peripheral Blood Mononuclear Cells: Dysregulated in Ulcerative Colitis and a Potential Role for CCL20 in IL-1β Release
por: Skovdahl, Helene Kolstad, et al.
Publicado: (2018)

The roles of Y-box-binding protein (YB)-1 and C-X-C motif chemokine ligand 14 (CXCL14) in the progression of prostate cancer via extracellular-signal-regulated kinase (ERK) signaling
por: Wang, Chen, et al.
Publicado: (2021)

Chemokine C-C Motif Ligand 7 (CCL7), a Biomarker of Atherosclerosis, Is Associated with the Severity of Alopecia Areata: A Preliminary Study
por: Waśkiel-Burnat, Anna, et al.
Publicado: (2021)

C–C motif chemokine CCL11 is a novel regulator and a potential therapeutic target in non-alcoholic fatty liver disease
por: Fan, Zhiwen, et al.
Publicado: (2023)

Predictability performance of urinary C–C motif chemokine ligand 14 and renal resistive index for persistent sepsis-associated acute kidney injury in ICU patients
por: Jiang, Wei, et al.
Publicado: (2023)

Use of Biomarkers to Identify Acute Kidney Injury to Help Detect Sepsis in Patients With Infection
por: Kellum, John A., et al.
Publicado: (2021)

Chemokines CCL2, 3, 14 stimulate macrophage bone marrow homing, proliferation, and polarization in multiple myeloma
por: Li, Yi, et al.
Publicado: (2015)

Cytotoxic chemotherapy reduces T cell trafficking to the spleen by downregulating the expression of C-C motif chemokine ligand 21 and C-C motif chemokine ligand 19
por: Liu, Lina, et al.
Publicado: (2018)

Low Systemic Levels of Chemokine C-C Motif Ligand 3 (CCL3) are Associated with a High Risk of Venous Thromboembolism in Patients with Glioma
por: Mir Seyed Nazari, Pegah, et al.
Publicado: (2019)

C-C Motif Chemokine Ligand 2 (CCL2) Mediates Acute Lung Injury Induced by Lethal Influenza H7N9 Virus
por: Lai, Chengcai, et al.
Publicado: (2017)

Breast Cancer: Coordinated Regulation of CCL2 Secretion by Intracellular Glycosaminoglycans and Chemokine Motifs()()
por: Lebel-Haziv, Yaeli, et al.
Publicado: (2014)

Cell-cycle arrest and acute kidney injury: the light and the dark sides
por: Kellum, John A., et al.
Publicado: (2016)

TIMP2•IGFBP7 biomarker panel accurately predicts acute kidney injury in high-risk surgical patients
por: Gunnerson, Kyle J., et al.
Publicado: (2016)

Potentials of C‐C motif chemokine 2–C‐C chemokine receptor type 2 blockers including propagermanium as anticancer agents
por: Yumimoto, Kanae, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nk1qvbb3e14o5121srkbfhmgt5